Understanding who benefits most from cognitive rehabilitation for multiple sclerosis: A secondary data analysis
Multiple Sclerosis Journal · 2023
DOI: 10.1177/13524585231189470 ↗Kurz gefasst
Fachartikel in der Zeitschrift Multiple Sclerosis Journal, 2023. Verfasst von L A Taylor und 4 weiteren Autor:innen. Beteiligte Einrichtung: Mental Health and Clinical Neurosciences Unit, School of Medicine, Institute of Mental Health, University of Nottingham, Nottingham, UK. Hauptthemen laut MEDLINE: Multiple Sclerosis, Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Relapsing-Remitting. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Multiple Sclerosis Society.
Abstract (Originalsprache)
Background
Up to 70% of people with multiple sclerosis (MS) experience cognitive difficulties. Cognitive rehabilitation is a type of therapy that helps manage cognitive problems.
Objective
The Cognitive Rehabilitation for Attention and Memory in MS (CRAMMS) trial showed some evidence of effectiveness of cognitive rehabilitation in improving cognitive function, with some participants benefitting more than others. We therefore conducted a secondary analysis of the CRAMMS data to understand who benefits most.
Methods
We grouped baseline data into four categories of possible predictors. We used regression models to identify specific factors/characteristics that could predict the likelihood that an individual will benefit from cognitive rehabilitation.
Results
The models predicted whether a participant improved or did not improve in neuropsychological function following cognitive rehabilitation in up to 86% of participants. Results suggest that younger participants with medium to high education, diagnosed with relapsing-remitting multiple sclerosis (RRMS) and primary-progressive multiple sclerosis (PPMS) who have not experienced any recent relapses, with mild to moderate cognitive difficulties were most likely to benefit from cognitive rehabilitation.
Conclusion
We can predict which participants are most likely to demonstrate significant improvements in neuropsychological function following group-based cognitive rehabilitation. Clinically, this allows us to optimise limited neuropsychology resources by offering such cognitive rehabilitation to those most likely to benefit.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Mental Health and Clinical Neurosciences Unit, School of Medicine, Institute of Mental Health, University of Nottingham, Nottingham, UK.
- College of Social Science, University of Lincoln, Lincoln, UK.
- Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK.
- Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK; SINTEF Digital, Trondheim, Norway.
ORCID-Profile: L A Taylor, J R Mhizha-Murira, G Law, N Evangelou, R das Nair
Förderung
- Multiple Sclerosis Society
Zitieren
APA
Taylor, L. A., Mhizha-Murira, J. R., Law, G., Evangelou, N., & das Nair, R. (2023). Understanding who benefits most from cognitive rehabilitation for multiple sclerosis: A secondary data analysis. Multiple Sclerosis Journal. https://doi.org/10.1177/13524585231189470
Vancouver
Taylor LA, Mhizha-Murira JR, Law G, Evangelou N, das Nair R. Understanding who benefits most from cognitive rehabilitation for multiple sclerosis: A secondary data analysis. Multiple Sclerosis Journal. 2023. doi:10.1177/13524585231189470
BibTeX
@article{Taylor2023,
author = {Taylor, L A and Mhizha-Murira, J R and Law, G and Evangelou, N and das Nair, R},
title = {Understanding who benefits most from cognitive rehabilitation for multiple sclerosis: A secondary data analysis},
journal = {Multiple Sclerosis Journal},
year = {2023},
doi = {10.1177/13524585231189470}
}
EUVIMED